SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about newspaper publication

27 May 2026 Evaluate
Lyka Labs has informed that as per regulation 47 of the SEBI (LODR) Regulations, 2015 the extract of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2026 were published in Financial Express English all edition and Janadesh Guajarati edition on 27th May 2026.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

60.27 2.87 (5.00%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×